Davey B. Daniel - Researcher Profile

Publications

2 shown

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

Scott Antonia , Augusto Villegas , Davey B. Daniel +30 more

Durvalumab therapy resulted in significantly longer overall survival than placebo. No new safety signals were identified. (Funded by AstraZeneca; PACIFIC ClinicalTrials.gov numb...

2018 New England Journal of Medicine 2682 citations

Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial

Howard West , Michael McCleod , Maen Hussein +17 more

Atezolizumab (a monoclonal antibody against PD-L1), which restores anticancer immunity, improved overall survival in patients with previously treated non-small-cell lung cancer ...

2019 The Lancet Oncology 1597 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 4,279
Institution: Florida Hospital Cancer Institute

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-9647-0119

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.